Table 3. Multiple Logistic Regression of Characteristics of Patients With ICH Comparing Odds of Neurologic Disability or Mortality After ICH^a.

Variable	Estimate (SE)	Odds ratio (95% CI)	P value
Log of ICH volume	1.01 (0.08)	2.74 (2.36-3.19)	<.001
ICH location
Brainstem	1.39 (0.28)	4.03 (2.34-6.95)	<.001
Cerebellum	−0.53 (0.24)	0.59 (0.37-0.94)	.03
Deep	NA	1 [Reference]	NA
Lobar	−1.53 (0.17)	0.22 (0.16-0.30)	<.001
Prestroke mRS score	0.48 (0.07)	1.62 (1.41-1.87)	<.001
Admission GCS score	−0.12 (0.02)	0.88 (0.85-0.92)	<.001
Age, per 1-y increase	0.04 (0.006)	1.04 (1.02-1.05)	<.001
Presence of infection	0.62 (0.13)	1.85 (1.42-2.41)	<.001
Hematoma expansion	0.79 (0.18)	2.20 (1.55-3.13)	<.001
Treatment required
ICP treatment	0.74 (0.18)	2.09 (1.46-3.00)	<.001
Tracheostomy	1.84 (0.52)	6.31 (2.29-17.35)	<.001
Intraventricular drain	0.64 (0.19)	1.89 (1.30-2.74)	<.001
Total Graeb score	0.11 (0.03)	1.12 (1.05-1.18)	<.001
Female sex	0.43 (0.13)	1.53 (1.19-1.98)	.001
Prior use of α-2 adrenergic	0.81 (0.27)	2.24 (1.32-3.82)	.003
Total van Swieten score	0.14 (0.05)	1.15 (1.04-1.26)	.005
Medical history
Alzheimer or dementia	0.92 (0.30)	2.51 (1.40-4.51)	.002
Migraine	−0.97 (0.38)	0.38 (0.18-0.80)	.01
Ischemic stroke	0.48 (0.20)	1.62 (1.11-2.37)	.01
Diabetes	0.34 (0.14)	1.40 (1.07-1.83)	.01
Cardiomyopathy	0.77 (0.35)	2.15 (1.08-4.27)	.03
ICH	0.46 (0.27)	1.59 (0.94-2.68)	.08
Hypertension	0.22 (0.18)	1.24 (0.88-1.75)	.22
Total atrophy score	0.15 (0.06)	1.16 (1.03-1.31)	.02
APOE 2 allele	0.36 (0.17)	1.43 (1.02-2.01)	.04
Clinical seizure	0.45 (0.23)	1.56 (1.00-2.43)	.05
Prior use of anticoagulants	−0.24 (0.20)	0.79 (0.53-1.16)	.23

Abbreviations: GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; ICP, intracranial pressure; mRS, modified Rankin Scale; NA, not applicable.

^a Model based on Akaike information criteria. Odds ratios were computed for a change of 1 for continuous variables. Analysis includes patients who had withdrawal of care.